View of Epicatechin as a potential hit to target ERK2 in breast cancer: molecular docking, molecular dynamic simulation studies

Return to Article Details Epicatechin as a potential hit to target ERK2 in breast cancer: molecular docking, molecular dynamic simulation studies Download Download PDF